Flow cytometric analysis of peripheral blood mononuclear cells from patients with advanced COVID-19 showed a significant rise in activated CD4+ T cells and CD14+HLA-DRlo inflammatory monocytes known to produce granulocyte-macrophage colony-stimulating factor (GM-CSF) [43, 44]. The gene discussed is CSF2; the disease is COVID-19.